Arterial thrombosis with anti-phospholipid antibodies induced by infliximab.
Nosbaum
Audrey
A
UCB Lyon I, Inserm U851, Clinical Immunology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69495, Pierre Bénite Cedex, France.
Goujon
Catherine
C
Fleury
Bertrand
B
Guillot
Isabelle
I
Nicolas
Jean-François
JF
Bérard
Frédéric
F
D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D016736:Antiphospholipid Syndrome / Q000139:chemically induced*; D005260:Female; D005263:Femoral Artery / Q000473:pathology; D006801:Humans; D007083:Iliac Artery / Q000473:pathology; D007155:Immunologic Factors / Q000009:adverse effects*; D000069285:Infliximab; D011565:Psoriasis / Q000188:drug therapy; D013927:Thrombosis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab